Ruvazone

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C12H14N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O5U67O8927, chemically known as pyruvic acid, o-ethoxybenzoylhydrazone but generally known as ruvazone, which bears US NIH Compound Identifier 9570360. European Medicines Agency schedules Ruvazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10408MIG. The term RUVAZONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). RUVAZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ruvazone under HS 29280090 and SITC 51486. As of Q4 2014, RUVAZONE remains the US FDA Preferred Term for this commodity. Ruvazone bears US NLM identifiers UMLS ID C0073726 and NCI Concept Code C90906. SMILES: CCOC1=CC=CC=C1C(=O)N/N=C(\C)/C(=O)O.